Cookson Peirce & Co’s Teladoc Health TDOC Stock Holding History

Cookson Peirce & Co’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,084	Closed	-$217K	–	206
2020 Q4	$217K	Buy	1,084 +121	+13%	+$24.6K	0.01%	149
2020 Q3	$211K	Buy	+963	New	+$204K	0.02%	135

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Cookson Peirce & Co's TDOC Position: Q1 2021 in Review

Cookson Peirce & Co sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 1,084 shares — an estimated $217K sold.

Cookson Peirce & Co first reported a position in TDOC in Q3 2020 and held it in 2 quarters. The position peaked at $217K in Q4 2020. 889 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

Cookson Peirce & Co reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
Cookson Peirce & Co sold 1,084 Teladoc Health shares in Q1 2021, an estimated $217K.
Cookson Peirce & Co first reported a position in Teladoc Health in Q3 2020 and held it in 2 quarters.
Cookson Peirce & Co's Teladoc Health position peaked at $217K in Q4 2020.
889 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Cookson Peirce & Co's 13F filing for Q1 2021, filed 11 May 2021.